Publications by authors named "Sue Ching Lin"

Claim this Profile
F
Folotyn (pralatrexate injection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summary.
Shakun M Malik, Ke Liu, Xu Qiang, Rajeshwari Sridhara, Shenghui Tang, Sue Ching Lin, Milinda Vialpando

Clin Cancer Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation.
Michael Brave, Ann Farrell, Sue Ching Lin, Terrance Ocheltree, Sarah Pope Miksinski

Oncology· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis